Ashley has over 9 years’ experience in Clinical Data Management both within the CRO and Pharmaceutical industries. Ashley started his career in the late phase Data Management department at PAREXEL working on numerous trials, across multiple therapeutic areas and in a variety of EDC systems. He progressed into a Data Management operational leadership position where he had overall accountability, as an account lead, for the execution of the Data Management strategy on numerous complex Oncology studies.
Ashley joined the Oncology team within the Data Monitoring and Management department at Pfizer in 2018 and is currently assigned to a number of key pivotal trials. He is an Oracle InForm EDC SME and his putting his knowledge and experience to good use working on a number of internal process development initiatives.
Andrew has over 20 years data management experience in the industry spread across several Pharmaceutical companies and CROs. He has a degree in Biological Sciences and a Postgraduate Diploma in Clinical Data Management. He currently is working as an Asset Lead in Data Management within the Oncology therapeutic area at Pfizer. He is also a former board member and treasurer of the ACDM.
Title of Session: Rebalancing The Pendulum: Rethinking the Big Pharma Sourcing Strategy
Description of Session:
After initiating and rolling out a comprehensive study operations outsourced model in 2012, the largest prescription pharmaceutical company in the world is now rethinking its strategy and carefully balancing the sourcing pendulum. Pfizer is reinventing itself and combining strategic insourcing in various geographic locations, while continuing to utilize key outside partners in a preferred provider capacity. This presentation will outline how this new approach is designed to more effectively support Pfizer’s very large portfolio of studies and deliver quality submissions across a wide variety of therapeutic areas, with best in class metrics.
Opportunity to share how Pfizer is re-establishing Data Management as a core competency within the organization
Discuss sponsor oversight and accountability of trial data according to ICHE6 guidelines
Explore why Pfizer is streamlining, updating and integrating its processes and use of technology to accelerate the availability of critical medicines to meet unmet medical needs